General Resources
These resources relate to the issues that MeTA is concerned with, both internally and externally produced. Clicking on one of the links may take you away from the MeTA website, to the source of that information.
Pfizer collaborate to increase access to medicines and health care in China
Pfizer and microfinance specialist PlaNet Finance are collaborating on an in-depth research project on the healthcare needs of the working poor in China.
Drug shortage hits Uganda
The latest survey from the Uganda Country Working Group shows 32-50 per cent of essential medicines for common diseases are not available
Drug giant GlaxoSmithKline pledges cheap medicine for world's poor
The world's second biggest pharmaceutical company is to radically shift its attitude to providing cheap drugs to millions of people in the developing world.
Poverty, not pharmaceutical patents, is the leading factor to a lack of access to essential medicines in developing countries.
A study from the Royal Institute of International affairs suggests that rather than patents limiting access to essential medicines in developing countries, it is poverty.
High inefficiency cited in distribution of medicine
A report of the MeTA Ghana launch from the Ghana News Agency
Medicines and poverty
MeTA to help tackle affordability and corruption (The Guardian, UK) - 24 September 2008